Effects of unfractionated and fractionated heparins on myeloperoxidase activity and interactions with endothelial cells: Possible effects on the pathophysiology of equine laminitis

Veterinary Journal

Volumn 178, Issue 1, 2008, Pages 62-69

  de la Rebiere G ^a   Franck, T ^a   Deby Dupont, G ^a   Salciccia, A ^a   Grulke, S ^a   Peters F ^a   Serteyn, D ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Endothelial cell culture; Equine laminitis; Heparin; Inflammation; Myeloperoxidase

Indexed keywords

HEPARIN; MYELOPEROXIDASE;

ANIMAL CELL; ANIMAL LAMENESS; ANTIINFLAMMATORY ACTIVITY; ARTERY ENDOTHELIUM; ARTICLE; CELL CULTURE; CELL INTERACTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIGITAL ARTERY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME PURIFICATION; HORSE DISEASE; NONHUMAN; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; CELLS, CULTURED; ENDOTHELIAL CELLS; FOOT DISEASES; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HORSE DISEASES; HORSES; PEROXIDASE;

EQUIDAE;

EID: 50449097145     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2007.08.033     Document Type: Article

References (56)

1. Anon. Lameness and Laminitis in U.S. horses. USDA:APHIS:VS (2000), CEAH, National Animal Health Monitoring System, Fort Collins, Colorado. N318.0400
2. Bailey S.R. The pathogenesis of acute laminitis: fitting more pieces into the puzzle. Equine Veterinary Journal 36 (2004) 199-203
3. Baldus S., Eiserich J.P., Mani A., Castro L., Figueroa M., Chumley P., Ma W., Tousson A., White C.R., Bullard D.C., Brennan M.L., Lusis A.J., Moore K.P., and Freeman B.A. Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. Journal of Clinical Investigation 108 (2001) 1759-1770
4. Baldus S., Heitzer T., Eiserich J.P., Lau D., Mollnau H., Ortak M., Petri S., Goldmann B., Duchstein H.J., Berger J., Helmchen U., Freeman B.A., Meinertz T., and Munzel T. Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. Free Radical Biology and Medicine 37 (2004) 902-911
5. Baldus S., Rudolph V., Roiss M., Ito W.D., Rudolph T.K., Eiserich J.P., Sydow K., Lau D., Szocs K., Klinke A., Kubala L., Berglund L., Schrepfer S., Deuse T., Haddad M., Risius T., Klemm H., Reichenspurner H.C., Meinertz T., and Heitzer T. Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase. Circulation 113 (2006) 1871-1878
6. Baxter G.M. Alterations of endothelium-dependent digital vascular responses in horses given low-dose endotoxin. Veterinary Surgery 24 (1995) 87-96
7. Benbarek H., Grulke S., Deby-Dupont G., Deby C., Mathy-Hartert M., Caudron I., Dessy-Doize C., Lamy M., and Serteyn D. Cytotoxicity of stimulated equine neutrophils on equine endothelial cells in culture. Equine Veterinary Journal 32 (2000) 327-333
8. Berhane Y., Elliott J., and Bailey S.R. Assessment of endothelium-dependent vasodilation in equine digital resistance vessels. Journal of Veterinary Pharmacology and Therapeutics 29 (2006) 387-395
9. Biasucci L.M., D'Onofrio G., Liuzzo G., Zini G., Monaco C., Caligiuri G., Tommasi M., Rebuzzi A.G., and Maseri A. Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia. Journal of the American College of Cardiology 27 (1996) 611-616
10. Black S.J., Lunn D.P., Yin C., Hwang M., Lenz S.D., and Belknap J.K. Leukocyte emigration in the early stages of laminitis. Veterinary Immunology and Immunopathology 109 (2006) 161-166
11. Christer Busch P. Sulfated glycosaminoglycans and vascular endothelial cells. In: Jaffe E.A. (Ed). Biology of Endothelial Cells (1984), Martinus Nijhoff Publishers, Hingham, USA 179-180
12. Cogswell A.M., Johnson P.J., and Adams H.R. Evidence for endothelium-derived relaxing factor/nitric oxide in equine digital arteries. American Journal of Veterinary Research 56 (1995) 1637-1641
13. Cohen N.D., Parson E.M., Seahorn T.L., and Carter G.K. Prevalence and factors associated with development of laminitis in horses with duodenitis/proximal jejunitis: 33 cases (1985-1991). Journal of the American Veterinary Medical Association 204 (1994) 250-254
14. Daphna E.M., Michaela S., Eynat P., Irit A., and Rimon S. Association of myeloperoxidase with heparin: oxidative inactivation of proteins on the surface of endothelial cells by the bound enzyme. Molecular and Cellular Biochemistry 183 (1998) 55-61
15. Deby-Dupont G., Deby C., and Lamy M. Neutrophil myeloperoxidase revisited: its role in health and disease. Intensivmed 36 (1999) 500-513
16. Derhaschnig U., Pernerstorfer T., Knechtelsdorfer M., Hollenstein U., Panzer S., and Jilma B. Evaluation of anti-inflammatory and antiadhesive effects of heparins in human endotoxemia. Critical Care Medicine 31 (2003) 1108-1112
17. Dotan I., Hershkoviz R., Karmeli F., Brazowski E., Peled Y., Rachmilewitz D., and Halpern Z. Heparin and low-molecular-weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats. Alimentary Pharmacology and Therapeutics 15 (2001) 1687-1697
18. Eades, S.C., Holm, A.S., Moore, R.M., 2002. A review of the pathophysiology and treatment of acute laminitis: pathophysiologic and therapeutic implications of endothelin-1. In: Proceedings of the 48th American Association of Equine Practitioners Annual Convention, Orlando, USA. pp. 353-361.
19. Eades S.C., Stokes A.M., Johnson P.J., Leblanc C.J., Ganjam V.K., Buff P.R., and Moore R.M. Serial alterations in digital hemodynamics and endothelin-1 immunoreactivity, platelet-neutrophil aggregation, and concentrations of nitric oxide, insulin, and glucose in blood obtained from horses following carbohydrate overload. American Journal of Veterinary Research 68 (2007) 87-94
20. Elliott J., Bryant C.E., and Soydan J. The role of nitric oxide in the responses of equine digital veins to vasodilator and vasoconstrictor agents. Equine Veterinary Journal 26 (1994) 378-384
21. Franck T., Grulke S., Deby-Dupont G., Deby C., Duvivier H., Peters F., and Serteyn D. Development of an enzyme-linked immunosorbent assay for specific equine neutrophil myeloperoxidase measurement in blood. Journal of Veterinary Diagnostic Investigation 17 (2005) 412-419
22. Franck T., Kohnen S., Deby-Dupont G., Grulke S., Deby C., and Serteyn D. A specific method for measurement of equine active myeloperoxidase in biological samples and in in vitro tests. Journal of Veterinary Diagnostic Investigation 18 (2006) 326-334
23. French K.R., and Pollitt C.C. Equine laminitis: loss of hemidesmosomes in hoof secondary epidermal lamellae correlates to dose in an oligofructose induction model: an ultrastructural study. Equine Veterinary Journal 36 (2004) 230-235
24. Gebrane-Younes J., Drouet L., Caen J.P., and Orcel L. Heterogeneous distribution of Weibel-Palade bodies and von Willebrand factor along the porcine vascular tree. American Journal of Pathology 139 (1991) 1471-1484
25. Grulke S., Benbarek H., Caudron I., Deby-Dupont G., Mathy-Hartert M., Farnir F., Deby C., Lamy M., and Serteyn D. Plasma myeloperoxidase level and polymorphonuclear leukocyte activation in horses suffering from large intestinal obstruction requiring surgery: preliminary results. Canadian Journal of Veterinary Research 63 (1999) 142-147
26. Grulke, S., Franck, T., Gangl, M., Peters, F., Salciccia, A., Deby-Dupont, G., Serteyn, D., in press. Myeloperoxidase assay in plasma and peritoneal fluid of horses with gastro-intestinal diseases. Canadian Journal of Veterinary Research.
27. Harada N., Okajima K., and Uchiba M. Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats. Critical Care Medicine 34 (2006) 1883-1891
28. Hinckley, K.A., Henderson, I.W., 1996. The epidemiology of equine laminitis in the UK. In: Proceedings of the 35th Congress of the British Equine Veterinary Congress, Warwick, UK. p. 62.
29. Hood D.M., Grosenbaugh D.A., Mostafa M.B., Morgan S.J., and Thomas B.C. The role of vascular mechanisms in the development of acute equine laminitis. Journal of Veterinary Internal Medicine 7 (1993) 228-234
30. Hurley D.J., Parks R.J., Reber A.J., Donovan D.C., Okinaga T., Vandenplas M.L., Peroni J.F., and Moore J.N. Dynamic changes in circulating leukocytes during the induction of equine laminitis with black walnut extract. Veterinary Immunology and Immunopathology 110 (2006) 195-206
31. Johnson R.J., Couser W.G., Chi E.Y., Adler S., and Klebanoff S.J. New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system. Journal of Clinical Investigation 79 (1987) 1379-1387
32. Johnson P.J., Messer N.T., and Ganjam V.K. Cushing's syndromes, insulin resistance and endocrinopathic laminitis. Equine Veterinary Journal 36 (2004) 194-198
33. Katwa L.C., Johnson P.J., Ganjam V.K., Kreeger J.M., and Messer N.T. Expression of endothelin in equine laminitis. Equine Veterinary Journal 31 (1999) 243-247
34. Katz L.M., Marr C.M., and Elliott J. Characterisation of the response of equine digital arteries and veins to substance P. Journal of Veterinary Pharmacology and Therapeutics 26 (2003) 361-368
35. Kjellen L., and Lindahl U. Proteoglycans: structures and interactions. Annual Review of Biochemistry 60 (1991) 443-475
36. Klebanoff S.J. Myeloperoxidase: friend and foe. Journal of Leukocyte Biology 77 (2005) 598-625
37. Leculier C., Couprie N., Adeleine P., Leitienne P., Francina A., and Richard M. The effects of high molecular weight- and low molecular weight-heparins on superoxide ion production and degranulation by human polymorphonuclear leukocytes. Thrombosis Research 69 (1993) 519-531
38. Manduteanu I., Voinea M., Antohe F., Dragomir E., Capraru M., Radulescu L., and Simionescu M. Effect of enoxaparin on high glucose-induced activation of endothelial cells. European Journal of Pharmacology 477 (2003) 269-276
39. Middleton J., Neil S., Wintle J., Clark-Lewis I., Moore H., Lam C., Auer M., Hub E., and Rot A. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91 (1997) 385-395
40. Moore B.R., and Hinchcliff K.W. Heparin: a review of its pharmacology and therapeutic use in horses. Journal of Veterinary Internal Medicine 8 (1994) 26-35
41. Morgan S.J., Hood D.M., Wagner I.P., and Postl S.P. Submural histopathologic changes attributable to peracute laminitis in horses. American Journal of Veterinary Research 64 (2003) 829-834
42. Obunike J.C., Lutz E.P., Li Z., Paka L., Katopodis T., Strickland D.K., Kozarsky K.F., Pillarisetti S., and Goldberg I.J. Transcytosis of lipoprotein lipase across cultured endothelial cells requires both heparin sulfate proteoglycans and the very low density lipoprotein receptor. Journal of Biological Chemistry 276 (2001) 8934-8941
43. Pollitt C.C. Basement membrane pathology: a feature of acute equine laminitis. Equine Veterinary Journal 28 (1996) 38-46
44. Pycock J.F., Allen W.E., and Morris T.H. Rapid, single-step isolation of equine neutrophils on a discontinuous Percoll density gradient. Research in Veterinary Science 42 (1987) 411-412
45. Ranjbaran H., Wang Y., Manes T.D., Yakimov A.O., Akhtar S., Kluger M.S., Pober J.S., and Tellides G. Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells. Circulation 114 (2006) 1293-1300
46. Riggs L.M., Franck T., Moore J.N., Krunkosky T.M., Hurley D.J., Peroni J.F., de la Rebiere G., and Serteyn D.A. Neutrophil myeloperoxidase measurements in plasma, laminar tissue, and skin of horses given black walnut extract. American Journal of Veterinary Research 68 (2007) 81-86
47. Savage C.O., Gaskin G., Pusey C.D., and Pearson J.D. Myeloperoxidase binds to vascular endothelial cells, is recognized by ANCA and can enhance complement dependent cytotoxicity. Advances in Experimental Medicine and Biology 336 (1993) 121-123
48. Schneider D.A., Parks A.H., Eades S.C., and Tackett R.L. Palmar digital vessel relaxation in healthy horses and in horses given carbohydrate. American Journal of Veterinary Research 60 (1999) 233-239
49. Simionescu M., Simionescu N., Silbert J.E., and Palade G.E. Differentiated microdomains on the luminal surface of the capillary endothelium II. Partial characterization of their anionic sites. Journal of Cell Biology 90 (1981) 614-621
50. Sissi C., Lucatello L., Naggi A., Torri G., and Palumbo M. Interactions of low-molecular-weight semi-synthetic sulfated heparins with human leukocyte elastase and human cathepsin G. Biochemical Pharmacology 71 (2006) 287-293
51. Smith J.M., Meinkoth J.H., Hochstatter T., and Meyers K.M. Differential distribution of von Willebrand factor in canine vascular endothelium. American Journal of Veterinary Research 57 (1996) 750-755
52. Spencer J.L., Stone P.J., and Nugent M.A. New insights into the inhibition of human neutrophil elastase by heparin. Biochemistry 45 (2006) 9104-9120
53. Turek J.J., Templeton C.B., Bottoms G.D., and Fessler J.F. Flunixin meglumine attenuation of endotoxin-induced damage to the cardiopulmonary vascular endothelium of the pony. American Journal of Veterinary Research 46 (1985) 591-596
54. Vanhoutte P.M. Platelet-derived serotonin, the endothelium, and cardiovascular disease. Journal of Cardiovascular Pharmacology 17 Suppl. 5 (1991) S6-S12
55. Weiss D.J., Geor R.J., Johnston G., and Trent A.M. Microvascular thrombosis associated with onset of acute laminitis in ponies. American Journal of Veterinary Research 55 (1994) 606-612
56. Wu A.H. Markers for early detection of cardiac diseases. Scandinavian Journal of Clinical and Laboratory Investigation 240 Suppl. (2005) 112-121